InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Device and CMC Development Master Plan to Support IND-Enabling Study of SPC-15
Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, has entered into a Device and CMC Development Master Plan with medical technology provider Resyca BV. A joint venture between Bespak Group and Medspray Pharma BV, Resyca manufactures the formulation-specific microchip-based spray system that Silo has chosen for its lead candidate SPC-15, an…